Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 114

1.

Simplified and robust one-step radiosynthesis of [18 F]DCFPyL via direct radiofluorination and cartridge-based purification.

Dornan MH, Simard JM, Leblond A, Juneau D, Delouya G, Saad F, Ménard C, DaSilva JN.

J Labelled Comp Radiopharm. 2018 May 2. doi: 10.1002/jlcr.3632. [Epub ahead of print]

PMID:
29722070
2.

Role of Prostate MR Imaging in Radiation Oncology.

Ménard C, Paulson E, Nyholm T, McLaughlin P, Liney G, Dirix P, van der Heide UA.

Radiol Clin North Am. 2018 Mar;56(2):319-325. doi: 10.1016/j.rcl.2017.10.012. Epub 2017 Dec 14. Review.

PMID:
29420985
3.

Validation of MRI to TRUS registration for high-dose-rate prostate brachytherapy.

Poulin E, Boudam K, Pinter C, Kadoury S, Lasso A, Fichtinger G, Ménard C.

Brachytherapy. 2018 Mar - Apr;17(2):283-290. doi: 10.1016/j.brachy.2017.11.018. Epub 2018 Jan 10.

PMID:
29331575
4.

A comparison of early prostate-specific antigen decline between prostate brachytherapy and different fractionation of external beam radiation-Impact on biochemical failure.

Taussky D, Bedwani S, Meissner N, Bahary JP, Lambert C, Barkati M, Beauchemin MC, Ménard C, Delouya G.

Brachytherapy. 2018 Mar - Apr;17(2):277-282. doi: 10.1016/j.brachy.2017.11.014. Epub 2018 Jan 3.

PMID:
29306674
5.

Particle Filter-Based Target Tracking Algorithm for Magnetic Resonance-Guided Respiratory Compensation: Robustness and Accuracy Assessment.

Bourque AE, Bedwani S, Carrier JF, Ménard C, Borman P, Bos C, Raaymakers BW, Mickevicius N, Paulson E, Tijssen RHN.

Int J Radiat Oncol Biol Phys. 2018 Feb 1;100(2):325-334. doi: 10.1016/j.ijrobp.2017.10.004. Epub 2017 Oct 12.

PMID:
29157746
6.

Stereotactic Radiosurgery With or Without Whole-Brain Radiation Therapy for Limited Brain Metastases: A Secondary Analysis of the North Central Cancer Treatment Group N0574 (Alliance) Randomized Controlled Trial.

Churilla TM, Ballman KV, Brown PD, Twohy EL, Jaeckle K, Farace E, Cerhan JH, Anderson SK, Carrero XW, Garces YI, Barker FG 2nd, Deming R, Dixon JG, Burri SH, Chung C, Ménard C, Stieber VW, Pollock BE, Galanis E, Buckner JC, Asher AL.

Int J Radiat Oncol Biol Phys. 2017 Dec 1;99(5):1173-1178. doi: 10.1016/j.ijrobp.2017.07.045. Epub 2017 Aug 5.

7.

Dosimetric impact of intrafraction changes in MR-guided high-dose-rate (HDR) brachytherapy for prostate cancer.

Rink A, Borg J, Simeonov A, O'Leary G, Helou J, Ménard C, Chung P, Jaffray DA, Berlin A.

Brachytherapy. 2018 Jan - Feb;17(1):59-67. doi: 10.1016/j.brachy.2017.06.001. Epub 2017 Jul 29.

PMID:
28764881
8.

Pre-radiotherapy PSA progression is a negative prognostic factor in prostate cancer patients using 5‑alpha-reductase inhibitors.

Taussky D, Piotte J, Zorn KC, Zanaty M, Krishnan V, Lambert C, Bahary JP, Beauchemin MC, Barkati M, Ménard C, Delouya G.

Strahlenther Onkol. 2018 Jan;194(1):17-22. doi: 10.1007/s00066-017-1176-z. Epub 2017 Jul 10.

PMID:
28695317
9.

Comparison of external beam radiotherapy versus permanent seed brachytherapy as monotherapy for intermediate-risk prostate cancer - a single center Canadian experience.

Delouya G, Lambert C, Bahary JP, Beauchemin MC, Barkati M, Ménard C, Taussky D.

Can J Urol. 2017 Jun;24(3):8822-8826.

PMID:
28646937
10.

External Beam Radiotherapy Affects Serum Testosterone in Patients With Localized Prostate Cancer.

Pompe RS, Karakiewicz PI, Zaffuto E, Smith A, Bandini M, Marchioni M, Tian Z, Leyh-Bannurah SR, Schiffmann J, Delouya G, Lambert C, Bahary JP, Beauchemin MC, Barkati M, Ménard C, Graefen M, Saad F, Tilki D, Taussky D.

J Sex Med. 2017 Jul;14(7):876-882. doi: 10.1016/j.jsxm.2017.04.675. Epub 2017 May 22.

PMID:
28546065
11.

Improved outcomes with dose escalation in localized prostate cancer treated with precision image-guided radiotherapy.

Raziee H, Moraes FY, Murgic J, Chua MLK, Pintilie M, Chung P, Ménard C, Bayley A, Gospodarowicz M, Warde P, Craig T, Catton C, Bristow RG, Jaffray DA, Berlin A.

Radiother Oncol. 2017 Jun;123(3):459-465. doi: 10.1016/j.radonc.2017.04.003. Epub 2017 Apr 20.

PMID:
28434799
12.

Radiosurgery for brainstem metastases with and without whole brain radiotherapy: clinical series and literature review.

Murray L, Menard C, Zadeh G, Au K, Bernstein M, Millar BA, Laperriere N, Chung C.

J Radiat Oncol. 2017;6(1):21-30. doi: 10.1007/s13566-016-0281-4. Epub 2016 Oct 27.

13.

Neutrophil-lymphocyte ratio dynamics during concurrent chemo-radiotherapy for glioblastoma is an independent predictor for overall survival.

Mason M, Maurice C, McNamara MG, Tieu MT, Lwin Z, Millar BA, Menard C, Laperriere N, Milosevic M, Atenafu EG, Mason W, Chung C.

J Neurooncol. 2017 May;132(3):463-471. doi: 10.1007/s11060-017-2395-y. Epub 2017 Mar 22.

PMID:
28332000
14.

Prostate-specific antigen density is predictive of outcome in suboptimal prostate seed brachytherapy.

Benzaquen D, Delouya G, Ménard C, Barkati M, Taussky D.

Brachytherapy. 2017 Mar - Apr;16(2):348-352. doi: 10.1016/j.brachy.2016.12.004. Epub 2017 Jan 28.

PMID:
28143764
15.

MR elastography to measure the effects of cancer and pathology fixation on prostate biomechanics, and comparison with T 1, T 2 and ADC.

McGrath DM, Lee J, Foltz WD, Samavati N, van der Kwast T, Jewett MA, Chung P, Ménard C, Brock KK.

Phys Med Biol. 2017 Feb 7;62(3):1126-1148. doi: 10.1088/1361-6560/aa52f4.

16.

Dosimetric feasibility of ablative dose escalated focal monotherapy with MRI-guided high-dose-rate (HDR) brachytherapy for prostate cancer.

Hosni A, Carlone M, Rink A, Ménard C, Chung P, Berlin A.

Radiother Oncol. 2017 Jan;122(1):103-108. doi: 10.1016/j.radonc.2016.11.011. Epub 2016 Dec 1.

PMID:
27916416
17.
18.

Long-term outcomes of a phase II trial of moderate hypofractionated image-guided intensity modulated radiotherapy (IG-IMRT) for localized prostate cancer.

Lieng H, Pintilie M, Bayley A, Berlin A, Bristow R, Chung P, Gospodarowicz M, Huang R, Ménard C, Warde P, Catton C.

Radiother Oncol. 2017 Jan;122(1):93-98. doi: 10.1016/j.radonc.2016.10.017. Epub 2016 Nov 9.

PMID:
27838147
19.

Advancements in brachytherapy.

Tanderup K, Ménard C, Polgar C, Lindegaard JC, Kirisits C, Pötter R.

Adv Drug Deliv Rev. 2017 Jan 15;109:15-25. doi: 10.1016/j.addr.2016.09.002. Epub 2016 Sep 13. Review.

PMID:
27637454
20.

A prospective study of DWI, DCE-MRI and FDG PET imaging for target delineation in brachytherapy for cervical cancer.

Han K, Croke J, Foltz W, Metser U, Xie J, Shek T, Driscoll B, Ménard C, Vines D, Coolens C, Simeonov A, Beiki-Ardakani A, Leung E, Levin W, Fyles A, Milosevic MF.

Radiother Oncol. 2016 Sep;120(3):519-525. doi: 10.1016/j.radonc.2016.08.002. Epub 2016 Aug 12.

PMID:
27528120

Supplemental Content

Loading ...
Support Center